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Abstract
Context: Accurate assessment of insulin sensitivity may better identify individuals at increased risk of cardio-metabolic
diseases.
Objectives: To examine whether a combination of anthropometric, biochemical and imaging measures can better estimate
insulin sensitivity index (ISI) and provide improved prediction of cardio-metabolic risk, in comparison to HOMA-IR.
Design and participants: Healthy male volunteers (96 Chinese, 80 Malay, 77 Indian), 21 to 40 years, body mass index
18230 kg/m2. Predicted ISI (ISI-cal) was generated using 45 randomly selected Chinese through stepwise multiple linear
regression, and validated in the rest using non-parametric correlation (Kendall’s tau t). In an independent longitudinal
cohort, ISI-cal and HOMA-IR were compared for prediction of diabetes and cardiovascular disease (CVD), using ROC curves.
Setting: The study was conducted in a university academic medical centre.
Outcome measures: ISI measured by hyperinsulinemic euglycemic glucose clamp, along with anthropometric
measurements, biochemical assessment and imaging; incident diabetes and CVD.
Results: A combination of fasting insulin, serum triglycerides and waist-to-hip ratio (WHR) provided the best estimate of
clamp-derived ISI (adjusted R2 0.58 versus 0.32 HOMA-IR). In an independent cohort, ROC areas under the curve were
0.7760.02 ISI-cal versus 0.7660.02 HOMA-IR (p.0.05) for incident diabetes, and 0.7460.03 ISI-cal versus 0.6160.03 HOMA-
IR (p,0.001) for incident CVD. ISI-cal also had greater sensitivity than defined metabolic syndrome in predicting CVD, with a
four-fold increase in the risk of CVD independent of metabolic syndrome.
Conclusions: Triglycerides and WHR, combined with fasting insulin levels, provide a better estimate of current insulin
resistance state and improved identification of individuals with future risk of CVD, compared to HOMA-IR. This may be
useful for estimating insulin sensitivity and cardio-metabolic risk in clinical and epidemiological settings.
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Introduction
Insulin resistance, or reduced insulin sensitivity, is the key
pathophysiologic defect in type 2 diabetes mellitus, metabolic
syndrome and cardiovascular disease [1,2,3,4]. Accurate assess-
ment of insulin sensitivity helps to identify individuals at increased
risk of these diseases, and may help target preventive and
therapeutic efforts more effectively. The ‘‘gold standard’’ method
for the assessment of insulin sensitivity is the hyperinsulinemic
euglycemic clamp. This method estimates insulin sensitivity
directly by determining peripheral glucose disposal rate during
the steady-state of hyperinsulinemia when blood glucose is
maintained at euglycemic levels by an exogenous glucose infusion
[5]. Although it is widely-accepted as the reference method, the
euglycemic clamp is costly, labor- and time-consuming. Thus, this
approach is usually confined to research settings and is not feasible
in population studies.
The most commonly used surrogate measure of insulin
resistance is the homeostatic model of insulin resistance
(HOMA-IR) [6], which is a computation based on fasting insulin
and glucose values. It has moderate correlations (r =20.38 to
20.66) with insulin sensitivity measured by the clamp technique
[7,8]. Since insulin sensitivity is influenced by and associated with
other factors such as excess adiposity and dyslipidemia
[4,9,10,11,12,13,14,15], we hypothesize that a combination of
simple anthropometric and biochemical parameters might provide
a better estimate of insulin sensitivity than HOMA-IR. In this
study, we derive an estimate of insulin sensitivity based on
anthropometric and routine biochemical parameters. We examine
if this derived measure of insulin sensitivity offers any advantage
over HOMA-IR in identifying individuals with insulin resistance
and risk of future cardio-metabolic events.
Subjects and Methods
Ethics statement
For the Singapore Adult Metabolism Study (SAMS), ethical
approval was obtained from the National Healthcare Group
Domain Specific Review Board prior to conduct of the study, and
written informed consent was obtained from all participants.
For the independent longitudinal cohort, ethics approval was
obtained from two Institutional Review Boards (National Univer-
sity of Singapore and Singapore General Hospital). Written
informed consent was obtained before conduct of the study.
Singapore Adult Metabolism Study
Healthy male volunteers, aged 21–41 years and with body mass
index (BMI) between 18.5–30 kg/m2, were invited to participate
in SAMS. Individuals with known hypertension, diabetes mellitus,
dyslipidemia, ischemic heart disease, epilepsy or any medication
that might affect insulin sensitivity (eg, corticosteroids) were
excluded. Also excluded were individuals with recent changes in
or attempts to change body weight, bleeding diathesis, inaccessible
veins, recent investigational medicine use, or contraindications to
magnetic resonance imaging (MRI).
Anthropometric measures included height, weight, waist and
hip circumference, measured twice and the average taken, as well
as skinfold thicknesses at four sites (biceps, triceps, subscapular and
suprailiac), measured in triplicate. The waist-to-hip ratio (WHR)
was calculated by dividing waist circumference (in cm) by hip
circumference (HC, in cm). Percentage body fat was derived from
the skinfolds measured using the following formula [16]: Body fat
%=36.7 * log (sum of 4 skinfolds: triceps, biceps, subscapular and
suprailiac) 239.5.
All subjects also underwent a whole body Dual Energy X-ray
Absorptiometry (DEXA) scan (a single Hologic Discovery Wi
densitometer, Hologic, Inc, Massachusetts, USA) to estimate total
fat mass, and magnetic resonance imaging (MRI) of the abdomen
(3T Trio, Siemens AG, Medical Solutions, Germany) from lumbar
segments T12 to L5, to quantify subcutaneous and visceral fat.
Hyperinsulinemic euglycemic glucose clamp. Insulin
sensitivity was assessed using the euglycemic, hyperinsulinemic
clamp technique as previously described [17]. Subjects were
instructed to fast overnight (10–12 hours). On the following
morning, two cannulae were inserted, one for infusion of 20%
dextrose solution and insulin, and the second into a contralateral
vein for blood sampling. After baseline blood samples were taken,
insulin was infused at a fixed-rate of 40 mU/m2 body surface
area/minute for the duration of 120 minutes. Blood glucose
concentrations were measured at 5-minute intervals and the
infusion rate of 20% dextrose solution was adjusted to maintain
blood glucose concentration at 5.0 mmol/L (90 mg/dL) through-
out the clamp period. Blood glucose was measured using an
enzyme biosensor glucose analyzer (YSI 2300 STATPLUS, YSI
Incorporated, Life Sciences, USA). The insulin sensitivity index
(ISI-clamp) was calculated using the mean glucose disposal rate
during the final 30 minutes of the clamp experiment (mg/min/
mU/kg lean body mass).
Biochemical analyses. Blood samples were collected from
all participants in the morning after a 10-hour overnight fast.
Venous blood was drawn and collected in plain and fluoride
oxalate tubes and stored at 4uC for a maximum of 4 hours prior to
processing. All biochemical analyses were carried out at the
National University Hospital Referral Laboratory, which is
accredited by the College of American Pathologists. Serum total
cholesterol, triglyceride (TG), and high density lipoprotein
cholesterol levels were measured using an automated auto-
analyzer (ADVIA 2400, Siemens Medical Solutions Diagnostics,
USA). Low density lipoprotein cholesterol levels were calculated
using the Friedewald formula [18]. Insulin level was analyzed
using a sandwich assay with 2 monoclonal mouse anti-insulin
antibodies (ADVIA Centaur, Siemens Medical Solutions Diag-
nostics, USA).
Independent longitudinal cohort
We looked at data from participants from two cross-sectional
surveys, the National Health Survey (NHS 1992) [19] and the
National Health Survey (NHS 1998) [20], who repeated the health
survey between 2004 and 2007. Briefly, both studies were a
random sample of from the Singapore population, with dispro-
portionate sampling stratified by ethnicity to increase the number
of the minority ethnic groups (Malays and Asian Indians). Details
of participant characteristics and biochemical analysis have been
published previously [19,20].
A total of 6,302 subjects who participated in one of the NHS
(1992 or 1998), were recontacted between 2004 and 2007 for
follow up examination. Of these 4,023 subjects had complete data
for anthropometric parameters, biochemical measures and diabe-
tes mellitus (DM) and cardiovascular disease (CVD) status at
baseline (NHS 1992 or 1998) and follow-up. Subjects with DM
(n= 202) or CVD (n= 71) at baseline were excluded. Thus, a total
of 3,750 subjects were included for the final analysis.
Definitions
Diabetes mellitus was defined using fasting plasma glucose
based on ADA criteria, as well as history of diabetes/diabetes
medication. Cardiovascular disease in NHS 1992 was defined as
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history of ischaemic heart disease/angina/stroke. Cardiovascular
disease in NHS 1998 was defined as history of angina/stroke.
Cardiovascular disease at follow up was defined as history of
ischaemic heart disease/blockage of coronary arteries/angina/
stroke. Homeostatic Model of Assessment of Insulin Resistance
(HOMA-IR) was calculated as [I0 (mU/mL) 6 G0 (mmol/L)]
422.5 [6], I0 = fasting insulin, G0= fasting glucose.
Statistical analysis
A total of 253 subjects (96 Chinese, 80 Malay, and 77 Indian)
from SAMS with complete clamp, anthropometric and biochem-
ical data were included in the analysis. All variables were checked
for normality and log-transformed to improve normality assump-
tions as necessary. A sub-sample was drawn from the Chinese
subjects in the study using the random sampling option in the
statistical software to select approximately half of the subjects
available. In this sub-sample of individuals, Pearson’s correlation
coefficients were used to identify significant associations between
anthropometric, biochemical and imaging measures with ISI-
clamp. Stepwise multiple linear regression was performed to
identify predictors of ISI-clamp, and to generate the prediction
equation (ISI-cal). Alternative models were evaluated by compar-
ing the total variation explained by the models. Findings were
confirmed using robust regression. Bootstrapping was used to
generate bias corrected and accelerated confidence intervals for
the beta coefficients.
The equation was validated by comparing non-parametric
correlation coefficients (Kendall’s tau-a) between various estimates
of insulin sensitivity and ISI-clamp, and testing for significant
differences between the correlation coefficients (using the lincom
command in STATA). Lin’s concordance coefficient was also
calculated to estimate agreement between ISI-clamp and ISI-cal.
Receiver operating characteristic (ROC) curves were used to
compared the predictive function of different methods in
identifying individuals with insulin resistance, as defined by the
lowest tertile of insulin sensitivity by ISI-clamp, i.e. ISI #6.94 mg
min21 kg lean mass21 mU insulin21.
We then examined the ability of the derivative ISI-cal in
predicting cardio-metabolic events in an independent longitudinal
cohort. ISI-cal and HOMA-IR were calculated for the baseline
cohorts (NHS 1992 and NHS 1998). ROC curves were used to
compare predictive function between HOMA-IR and ISI-cal in
identifying new onset of DM and CVD in the follow – up cohort.
Youden’s index was used to identify cut-off values with optimum
specificity and sensitivity. McNemar’s statistic was used to test for
differences in sensitivity and specificity between ISI-cal and
metabolic syndrome definition in predicting CVD.
The random sample was generated using the random sampling
facility in SPSS (Version 19, IBM Statistics, USA). All other
statistical analyses were performed using Stata 10.0 for Windows
(Stata Corporation, College Station, Texas, USA). Data are
presented as means 6 SD unless stated otherwise. All statistical
tests were two-sided, with any p,0.05 being considered significant.
Results
Table 1 summarizes the characteristics of subjects from SAMS
and the independent cohort.
Generation of prediction equation
In the random sample of 45 Chinese subjects, various
anthropometric and biochemical measures were associated with
ISI-clamp on univariate analysis: BMI (r =20.45, p=0.002), waist
circumference (r =20.59, p,0.001), WHR (r =20.66, p,0.001),
skinfold-derived body fat% (r =20.63, p,0.001), DEXA derived
total body fat% (r =20.55, p,0.001), serum triglycerides
(r =20.46, p=0.001), fasting insulin (r =20.59, p,0.001), MRI
measured visceral (VAT, r =20.58, p,0.001) and subcutaneous
(SAT, r =20.56, p,0.001) adipose tissue.
To identify which set of variable(s) best explained the variation
in ISI-clamp, we examined several combinations of these variables
in separate regression models. A model with WHR (DR2 = 0.42),
I0 (DR
2 =0.13) and TG (DR2 = 0.04) best predicted insulin
sensitivity (total adjusted R2 = 0.58), over models with I0 alone
(adjusted R2 = 0.33), and HOMA-IR alone (adjusted R2 = 0.32).
Replacing WHR with various MRI-derived fat measures, VAT
(adjusted R2 = 0.52), SAT (adjusted R2 = 0.51), VAT/SAT ratio
(adjusted R2 = 0.46), VAT over hip circumference (adjusted R2
= 0.55), SAT over HC (adjusted R2 = 0.52), did not improve the
adjusted R2 over the model based on WHR, I0 and TG. Neither
did replacing fasting insulin with other surrogate measures of
insulin resistance, HOMA-IR (adjusted R2 = 0.55) or QUICKI
(adjusted R2 = 0.56). There was no multi-collinearity in the final
model (VIF ,1.5, tolerance 0.75). The relationship between these
variables and ISI-clamp was confirmed using robust regression,
and confidence intervals for the coefficients obtained by boot-
strapping (Table S1). The prediction equation finally derived was
given as ISI-cal = exp(2.65 – (2.63*ln [WHR]) – (0.39*ln




The prediction equation, ISI-cal, was validated using the
remaining 208 subjects from SAMS. Overall, the correlation
between ISI-clamp and ISI-cal (Kendall’s tau t=0.42, p,0.001)
was stronger than the correlation between ISI-clamp and HOMA-
IR (t=20.37, p,0.001) (p (comparison) = 0.045). The correlation
coefficients for ISI-cal and HOMA-IR, for Chinese (0.43 versus
=20.39) and Indians (0.34 versus =20.32) were not significant,
except for Malays (0.47 versus =20.38, p(comparison) = 0.03). Lin’s
concordance coefficient between ISI-clamp and ISI-cal was 0.53
for the whole group, 0.46 for Chinese, 0.6 for Malay and 0.42 for
Indian.
The predictive function of these indices in identifying individ-
uals with low insulin sensitivity was tested using ROC curves, with
the ISI cutoff set at 6.94 mg min=21 kg lean mass21 mU
insulin21 (the lowest tertile of insulin sensitivity in the group). For
this comparison, we used inverse values of HOMA-IR to indicate
insulin sensitivity. ISI-cal had a significantly larger area under the
ROC curve compared to HOMA-IR (0.82 versus 0.78, p=0.024)
(Figure 1).
Prediction of cardiometabolic events in an independent
longitudinal cohort
In the longitudinal cohort (with 6 to 15 years of follow-up),
there were 99 individuals who subsequently developed CVD (70
with ischaemic heart disease, 29 with stroke or transient ischaemic
attack, and 7 with both), and 213 who developed DM, among
those without DM or CVD at baseline. We compared the ability of
ISI-cal (inverse) and HOMA-IR in identifying these individuals
using ROCs. ISI-cal and HOMA-IR had similar AUCs in
predicting DM (Table 2). However, ISI-cal had a significantly
larger AUC compared to HOMA-IR in predicting CVD. These
findings were replicated across all three ethnic groups and in both
genders (Table 2). ISI-cal showed better discrimination for both
ischaemic heart disease (ROC ISI-cal 0.7560.03 vs HOMA-IR
0.6360.04, p,0.001) and stroke (ROC ISI-cal 0.7360.04 vs
HOMA-IR 0.5860.05, p,0.001).
Predicting Insulin Sensitivity
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Using Youden’s index, the optimal ISI-cal cut-off for predicting
DM was 9.3 with sensitivity and specificity of 71%, and for
predicting CVD was 9.23 with a sensitivity of 71% and specificity
of 70%. The optimal cut-offs for HOMA-IR in this population was
1.99 for DM with sensitivity 70% and specificity 71%, and 1.59 for
CVD with sensitivity 64% and specificity 54%. These results did
not change materially when we repeated the analysis by cohort of
origin (NHS 92, NHS 98) (data not shown).
We also examined whether ISI-cal and metabolic syndrome, as
defined by the NCEP ATP III criteria, performed comparably in
predicting CVD using McNemar’s statistic. We did this to verify
whether the gain in predictive accuracy over HOMA-IR was due
to improved estimation of the insulin resistance state, or due to the
inclusion of triglycerides and WHR, which are independent risk
factors for CVD. ISI-cal had a significantly higher sensitivity (70%)
compared to metabolic syndrome (25%; p,0.001), but also lower
specificity (71% ISI-cal vs 92% metabolic syndrome, p,0.001).
We also ran a logistic regression to evaluate if ISI-cal was
associated with future CVD events independent of metabolic
syndrome, and found that the association between CVD and ISI-
cal was highly significant (OR 4.7, 95% CI 2.9–7.4, p,0.001),
even when metabolic syndrome was in the model (OR 1.9, 95%
CI 1.1–3.1, p=0.02). There was no collinearity between ISI-cal
and metabolic syndrome in the model (VIF 1.2, tolerance 0.8).
Discussion
We derived a prediction equation of insulin sensitivity based on
three easily obtainable parameters, namely, waist-to-hip ratio,
fasting triglycerides and insulin. This prediction equation corre-
lated well with clamp-measured insulin sensitivity in a validation
group that was not used to generate the estimate. In a prospective
cohort, the prediction equation performed as well as HOMA-IR in
identifying individuals at risk of DM, but significantly better than
HOMA-IR in identifying individuals at risk of CVD. This was true
for all ethnic groups and for both genders.
Fasting insulin, fasting triglyceride and central adiposity are
known to be associated with insulin sensitivity; however a
combination of these parameters has not been used to estimate
insulin sensitivity. McLaughlin et al have shown that TG or TG-
high density lipoprotein ratio was as strongly associated with
insulin resistance as fasting insulin levels. They were also the lipid
parameters that best correlated with insulin resistance [13,15].
The equation that we have proposed is similar to the equation
described by McAuley et al except that we have included a
measure of central obesity, which has greater association with
development of insulin resistance and CVD compared to BMI
Table 1. Baseline characteristics of subjects in SAMS and an independent cohort.






(N=3750) At follow up
Variable Mean SD Mean SD Mean SD N Mean SD
Age 28 6.56 27 5.16 38 11.1 3748 47 11.11
Ethnicity, N, % 3661
Chinese 45 100 51 24.52 2,616 69.76 2,558 69.87
Malay 0 0 80 38.47 608 16.21 594 16.23
Indian 0 0 77 37.02 526 14.03 509 13.9
Gender, N % 3661
Male 45 100 208 100 1,748 46.6 1,706 46.6
Female 0 0 0 0 2,002 53.4 1,955 53.4
BMI 23.4 2.96 24.4 3.30 23.1 3.95 3745 23.7 4.31
FPG 4.76 0.38 4.64 0.48 5.41 0.5 3750 4.93 1.16
Total cholesterol 4.94 0.79 4.92 0.98 5.39 1.05 3745 5.22 0.93
Triglycerides 1.19 0.69 1.14 0.65 1.38 1.27 3745 1.33 0.84
Fasting insulin 9.47 4.93 11.67 7.75 7.53 5.48 3655 7.77 6.48
WHR 0.85 0.05 0.85 0.05 0.81 0.08 3655 0.85 0.08
ISI-clamp 10.38 4.12 9.8 5.1
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Reference
Figure 1. Comparison of ISI-cal with HOMA-IR in validation
group from the SAMS study. N= 208; P = 0.024 HOMA-IR –
homeostatic model of insulin resistance, ISI-cal – calculated insulin
sensitivity, SAMS – Singapore Adult Metabolism study.
doi:10.1371/journal.pone.0074410.g001
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[21,22,23]. McAuley et al proposed two prediction equations for
insulin sensitivity, one using TG and fasting insulin, and another
with inclusion of BMI, using a sample of 178 normoglycemic
subjects. They observed that when TG was included but not BMI,
there was a a modest but significant increase in sensitivity
compared to insulin alone in predicting insulin sensitivity [24]. In
our study, addition of WHR instead of BMI increased the ability
of our prediction equation to estimate insulin sensitivity. We have
further demonstrated the efficacy of this prediction equation in
predicting future cardio-metabolic risk.
Our prediction equation was more sensitive and specific than
HOMA-IR in predicting future CVD event. One obvious
explanation is that the prediction equation incorporates measures
of central adiposity and triglycerides, which are both associated
with insulin resistance and are independent risk factors for CVD.
To better understand this, we compared this prediction equation
with metabolic syndrome (whose defining criteria include three out
of the following five above predefined cut-offs – waist circumfer-
ence, triglyceride, HDL cholesterol, fasting glucose and blood
pressure) in predicting future CVD. We found that the prediction
equation had significantly higher sensitivity over metabolic
syndrome, and was independently associated with a four-fold
increase in the odds of future CVD. This indicates that the
improved prediction of CVD is due to obligatory inclusion of
WHR and TG in our equation, which allows for bothbetter
approximation of insulin resistance states, and improved predic-
tion of CVD. Additionally, the prediction equation uses continous
variables while metabolic syndrome uses binary variables, which
may also explain greater predictive accuracy for our equation
compared to metabolic syndrome. This equation could provide a
closer estimate for insulin sensitivity in predicting CVD and DM
risk especially in population studies. Unlike the metabolic
syndrome classification or available scoring systems, the prediction
equation also provides an independent continuous variable which
can be utilised for epidemiological research modeling.
The clinical utilty and strength of our study is that we have
developed an estimation for insulin sensitivity that was able to
predict both both future DM and CVD in an independent cohort.
One limitation is that CVD was defined by self-report and that
definitions of CVD were not identical at baseline and follow up.
However, we have no reason to suppose that this would affect one
test more than the other. Moreover, the area under the ROC
curve for HOMA-IR for prediction of DM and CVD in our study
is similar to that reported elsewhere [25].
In summary, we show that fasting triglycerides and waist hip
ratio are important determinants of insulin sensitivity, and can be
combined with fasting insulin levels to provide a more accurate
estimation of insulin sensitivity, and better prediction of future risk
of CVD than HOMA-IR.
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